企业信息
第7年
- 入驻时间： 2015-11-06
- 联系人：顾磊
- 电话：021-60514606
-
联系时，请说明易展网看到的
- Email：shybio@126.com
产品分类
产品详情
简单介绍：
Anti-eIF3B抗体供应商为您提供抗体的售前、售中、售后服务，现货供应，保证实验结果，无效可以免费退换，广泛应用于IHC、WB、 IF、IP、ELISA，质量保证，另外本公司生产经营各种单克隆抗体、多克隆抗体,标记二抗、**印迹常用试剂、**组化常用试剂，Anti-eIF3B抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-eIF3B
Cat. Number:
YB14542R
Quantity size:
0.1ml
Concentration:
Anti-eIF3B抗体1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
eIF3b expression relates to human bladder and prostate cancer prognosis, is required for tumor growth, and thus a candidate therapeutic target.The initiation of protein synthesis in eukaryotic cells is regulated by interactions between protein initiation factors and RNA molecules. Association of eIF3 proteins with the 40S ribosomal Anti-eIF3B抗体subunit stabilizes eIF2-GTP-Met-tRNAiMet complex association and mRNA binding, and promotes dissociation of 80S ribosomes into 40S and 60S subunits, thereby promoting the assembly of the pre-initiation complex. Overexpression of eIF3 proteins is common in several cancers, suggesting a role for eIF3 proteins in tumorigenesis.
Also known as:
eIF-3-eta; eIF3 eta; eIF3 p110; eIF3 p116; EIF3-ETA; EIF3-P110; EIF3-P116; eIF3b; EIF3B_HUMAN; Anti-eIF3B抗体EIF3S9; Eukaryotic translation initiation factor 3, subunit B; Eukaryotic translation initiation factor 3 subunit 9; eukaryotic translation initiation factor 3 subunit 9 eta; Eukaryotic translation initiation factor 3 subunit B; hPrt1; PRT1; Prt1 homolog.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit, Sheep, .
●
Immunogen:Anti-eIF3B抗体KLH conjugated synthetic peptide derived from human eIF3B.
●
Predicted Molecular Weight: 92kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-eIF3B抗体
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user
